AIMS: To examine the relationship between revascularization within 7 days and 1-year mortality among ST-elevation @entity583 @entity1 enrolled in GUSTO-V trial (n=13 451). To examine the relative contribution of system and @entity1 level factors to the variation in international revascularization rates, and their impact on mortality outcomes. METHODS AND RESULTS: @entity1 from North America (USA, Canada), Australia, and Europe (UK, France, Germany, Italy, Spain, Poland, Norway, The Netherlands, Belgium, Finland) were included in the study. Revascularization was associated with lower 1-year mortality. Norway, Belgium, Spain, Poland, and Italy also had lower than expected revascularization rates but higher than expected mortality rates. France and USA had almost two times the expected rate of 7-day revascularization, which was associated with modest mortality benefits. @entity1 ' propensity for revascularization based on clinical factors alone was associated with lower 1-year mortality (OR 0.97, 95% CI: 0.96-0.99). Country-level factors had an impact on propensity for revascularization but no impact on 1-year mortality. CONCLUSION: Our study reveals the potential for some countries with lower than expected 7-day revascularization rates to improve their clinical outcomes. Also highlighted is the possibility for more economically efficient delivery of care in USA and France.

Optimizing use of revascularization and clinical outcomes in ST-elevation XXXX : insights from the GUSTO-V trial.

@entity1 :: ('9606', 'Species') :: ['patient', 'patients', 'Patients'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction']
@entity583 :: (MESH:D009203,Disease) :: ['myocardial infarction']
